NZ HIV Medicine Research Review Issue 63
In this issue:
– DTG-3TC vs. BIC-FTC-TAF among Asians
– Cabotegravir-rilpivirine for people with HIV and adherence challenges
– Benzathine penicillin G and doxycycline for late/unknown duration syphilis
– Fixed-dose doravirine-islatravir in virologically suppressed HIV-1 on oral ART
– DePASS initiative: detecting HIV, HBV and HCV
– Safety and efficacy of ICIs in HIV
– Threshold effects of doxycycline PEP on the gut
– Assessing CV disease prevention in HIV: PCE, PREVENT or SCORE2
– Impact of condom use on the HIV epidemic
– Switching from DTG-3TC to BIC FTC-TAF: effects on inflammation/ metabolic parameters
Expert contributor
Dr Sarah Metcalf
Dr Sarah Metcalf is an Infectious Diseases and General Medicine Physician at Christchurch Hospital. She attended Medical School at the University of Otago, graduating in 1995 and completed post-graduate training at Christchurch Hospital specialising in Infectious Diseases and General Medicine in 2003. Following that she worked in Sheffield, United Kingdom to gain further experience in […]
Expert contributor
Dr Massimo Giola
Dr Massimo Giola obtained his medical degree in 1991 at the University of Pavia (Italy) and specialised in infectious diseases in 1996 (Italy). He studied antiretroviral drugs’ pharmacokinetics during a PhD programme in clinical and experimental pharmacology from 2005 to 2008 at the University of Varese (Italy). He moved to NZ in 2009 and worked […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.
